B₊labs’ Post

This March, I'm speaking at Central European BioForum. Those who follow our Viseven journey probably know that in 2019, we took a great focus on global expansion. Ever since came riveting times of new challenges, lessons, failures, and successes. During the panel discussion "How to enter the US market?" I'll gladly share how Viseven managed the intricacies of this global expansion and cooperation with bio-related companies. #CEBioForum2024 is said to be the place where you meet key players in biotech in CEE in one spot in order to find business development opportunities. Together with Nataliya Kulyba, Maciej Najdzion, Oleksandra Yashyna (Zikh), and Dominika Sosnowska, we're looking forward to this opportunity. Meanwhile, let's connect! #martech #biotech #globalbusiness

Our second life science event was another sell-out! Learning so much about the needs of life science tenants and properties. What should we talk about next?

Euronext was thrilled to sponsor the 24th edition of Bio€quity Europe, held from 12 to 14 May in San Sebastián, Spain. This year's event was highlighted by #Euronext's opening bell ceremony on the second day, which set the stage for a fantastic exchange of ideas and insights among participants. Sophie Stegen, Head of Listing at #EuronextBrussels, also joined an expert panel to discuss the key factors that biotech companies need to consider in order to attract investor attention in a buyers' market. For over two decades, Bio€quity Europe has served as a premier platform for CEOs and investors to connect, collaborate, and engage in discussions within the biotech industry. With over 120 Healthtech companies listed on our markets, Euronext proudly stands as the leading European stock exchange in this sector. We would like to express our gratitude to all the attendees and event organisers at Bio€quity for their contributions in making this year's event a success. For more information: https://lnkd.in/eWsgzae7 #BioEquityEurope #CapitalMarkets #Biotech 

We are pleased to share that Sean Coffey, SVP, Investments will speak next Thursday at Bisnow’s Boston Life Science Conference at the Seaport Hotel. Sean’s panel titled Navigating Funding & Deals Amidst Changing Interest Rates, will provide valuable insight on executing projects amidst challenging capital markets. Other topics covered at this year’s conference are major developments, evolving tenant needs, and how leasing dynamics and innovation hubs are enhancing greater Boston’s biotech ecosystem.   Register here: https://lnkd.in/dnj88-EU   #LifeScienceInvestments #BioTech #GreaterBostonLifeScience #LifeScienceRealEstate

Kickstarting this week with #Bio2024 in San Diego. Lots of interesting meetings and talks already, can’t wait to learn more about the attending companies and the possibility to collaborate with some of them. If you’re attending and want to learn about CrestOptics confocal spinning disk technologies, DM me or set a meeting with me through the partnering app. #biotech #networking #partnership #businessdevelopment #innovation

Life Science experts Adrian Toutoungi and Nicholas Vollers, review the key considerations from the Bruntwood SciTech event, hosted at our Cambridge office, for TechBio investors, CEOs and founders considering their exit strategy: https://bit.ly/430qo1G   Key takeaways include the importance of defining your product, an analysis of the types of exit opportunities available to TechBio companies, considerations when valuing assets and platforms, and how to approach a pharma collaboration.   #LifeSciences #TechBioExits #TechBioInvestors #PrivateWealth

Euronext was excited to sponsor the 24th edition of #Bio€quityEurope, held from 12 to 14 May in San Sebastián, Spain. This year's event was highlighted by Euronext's opening bell ceremony on the second day together with Joshua Berlin, Claire Macht and David Flores, which set the stage for a fantastic exchange of ideas and insights among participants. I had the honour to join an expert panel hosted by Erica Whittaker, head of corporate venture fund at UCB, to discuss the key factors that biotech companies need to consider in order to attract investor attention in a buyers' market. There's must haves for companies to attract funding. Next to solid data, you also need to have that excellent team that drives your company forward. And even though public markets in Europe are still rocky for Biotech companies, dare I say that there's light at the end of the tunnel? With over 120 Healthtech companies listed on our markets, Euronext proudly stands as the leading European stock exchange in this sector. We would like to express our gratitude to all the attendees and event organisers at Bio€quity for their contributions in making this year's event a success. For more information about Euronext: https://lnkd.in/eWBRXBmn #BioEquityEurope #CapitalMarkets #Biotech #Euronext

⭐️The Medici Effect ⭐️ Standing in front of the breathtaking Florence Cathedral, I can’t help but think of the Medici family and their incredible influence on fostering innovation. As Frans Johansson describes in, The Medici Effect, the collision of diverse ideas and disciplines can spark groundbreaking innovations. At the BioVentureHub we are embodying this very philosophy. By bringing together non-competitive, complementary skills, technologies, and competencies, we are creating an ecosystem where diversity fuels innovation. Just as the Medici family catalyzed the Renaissance, we are cultivating collaboration and cross-pollination of ideas that push the boundaries of what's possible in life science and biotech. Innovation thrives when diversity leads the way! #innovation #collaboration #BioVentureHub #MediciEffect #diversityandinclusion #biotech #lifesciences

One company optimizing protein conjugates, one company screening for optimal efficacy and therapeutic window of protein conjugates. Well played, #RESIBoston2024 #ADCs #startup #proteinconjugation

Come connect with me and my DC team today at the Bio Innovation Conference! Stop by our booth (#11) to learn how PwC supports emerging growth companies and leading biotechs. #MDLSBioInnovation